deltatrials
Terminated EARLY_PHASE1 INTERVENTIONAL 1-arm NCT00881556

Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB) (RDEB)

A Pilot Study of Reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLOSCT) In Children With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Sponsor: Columbia University

Conditions Epidermolysis Bullosa
Interventions Alemtuzumab Busulfan Fludarabine Lorazepam Palifermin Tacrolimus
Updated 7 times since 2017 Last updated: Aug 13, 2021 Started: Aug 20, 2009 Primary completion: Sep 30, 2015 Completion: Sep 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Columbia University

See all terminations from Columbia University

Other Epidermolysis Bullosa trials with similar outcome

Browse all Epidermolysis Bullosa trials

This EARLY_PHASE1 trial investigates Epidermolysis Bullosa and is currently terminated or withdrawn. Columbia University leads this study, which shows 7 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotUnknown Status~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 23 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated EARLY_PHASE1

  3. Sep 2021 — Jul 2024 [monthly]

    Terminated EARLY_PHASE1

    Status: Unknown Status → Terminated

  4. Jan 2021 — Sep 2021 [monthly]

    Unknown Status EARLY_PHASE1

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status EARLY_PHASE1

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Unknown Status EARLY_PHASE1

    Phase: Phase 0 → EARLY_PHASE1

  2. Jan 2017 — Feb 2017 [monthly]

    Unknown Status Phase 0

    First recorded

Aug 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Columbia University
Data source: Columbia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations